EMMES BIOPHARMA UK LIMITED

Company number 04498663 ·

Active - Proposal to Strike off

The confirmation statement for this company is overdue.

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£12,784,684

Balance sheet as at 2024-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2002-07-30
Registered office
Regus House Fairbourne Drive, Atterbury, Milton Keynes, England, MK10 9RG
Postcode
MK10 9RG
Capital
1,189 GBP
Accounts category
Group
Charges
0 outstanding

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2024-11-17
Next due by
2025-12-01 Overdue
View filing history →

Nature of business (SIC)

  • 72190 Other research and experimental development on natural sciences and engineering

Officers 3 current · 16 resigned

Peter RONCO Director
Appointed 2023-09-20
Appointed 2023-09-20
Appointed 2023-08-18

View all officers and resignations →

Contact details

Website
orphan-reach.com

CRO with focus on Rare Diseases and Orphan Drugs

Previous company names

NameDate changed
ORPHAN REACH LIMITED2023-01-05
QED CLINICAL SERVICES LIMITED2018-07-20
MONITORDIRECT LIMITED2002-10-01

Previous registered addresses 4

AddressChanged on
THE LEARNING HOUSE SNOWDON DRIVE, WINTERHILL, MILTON KEYNES, BUCKINGHAMSHIRE, MK6 1BP2018-04-09
TECHNOLOGY HOUSE, 151 SILBURY BOULEVARD, MILTON KEYNES, BUCKINGHAMSHIRE, MK9 1LH2009-10-12
TECHNOLOGY HOUSE, 151 SILBURY BOULEVARD, MILTON KEYNES, BUCKINGHAMSHIRE MK9 3AE2005-08-10
65 ULYETT PLACE, MILTON KEYNES, MK6 2SD2003-04-08

The class of 2002

34%

of the 221 companies in this sector incorporated in 2002 are still active today; 64% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →